- Report
- June 2026
- 193 Pages
Global
From €3182EUR$3,545USD£2,724GBP
€3536EUR$3,939USD£3,027GBP
- Report
- February 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,451GBP
- Report
- January 2026
- 281 Pages
Global
From €2244EUR$2,500USD£1,921GBP
- Report
- February 2026
- 160 Pages
Global
From €2980EUR$3,320USD£2,552GBP
€3726EUR$4,150USD£3,189GBP
- Report
- October 2025
- 160 Pages
Global
From €2837EUR$3,160USD£2,429GBP
€3546EUR$3,950USD£3,036GBP
- Report
- January 2026
- 199 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 182 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 186 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 196 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 182 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- June 2026
- 189 Pages
Global
From €3182EUR$3,545USD£2,724GBP
€3536EUR$3,939USD£3,027GBP
- Report
- November 2025
- 188 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 199 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2025
- 186 Pages
Global
From €3183EUR$3,545USD£2,725GBP
€3536EUR$3,939USD£3,027GBP
- Report
- August 2026
- 270 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- August 2026
- 340 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- January 2026
- 180 Pages
Global
From €4040EUR$4,500USD£3,458GBP
- Report
- January 2026
- 130 Pages
Global
From €4264EUR$4,750USD£3,651GBP
- Report
- March 2026
- 138 Pages
Global
From €4354EUR$4,850USD£3,727GBP
- Report
- December 2025
- 218 Pages
Global
From €4308EUR$4,799USD£3,688GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more